Menu Back to Pharmacovigilance-and-Risk-Management-Strategies-2015

Program Committee

  • William W. Gregory, PhD
    William W. Gregory, PhD Senior Director, Worldwide Safety and Regulatory
    Pfizer Inc, United States
  • Stella C.F. Blackburn, MD, MA, MSc, FFPM, FISPE, FRCP
    Stella C.F. Blackburn, MD, MA, MSc, FFPM, FISPE, FRCP Vice President, Global Head of Risk Management
    QuintilesIMS, United Kingdom
  • Mariette  Boerstoel-Streefland, MD, MBA, MS
    Mariette Boerstoel-Streefland, MD, MBA, MS Senior Vice President, Head Global Drug Safety
    Shire, United States
  • JP  Clement, MD
    JP Clement, MD Executive Consultant
    JP Clement PV Consulting, United States
  • Stephen  Knowles, MD, MRCP
    Stephen Knowles, MD, MRCP Senior Director, Global Patient Safety, Medical and Benefit Risk Management
    Eli Lilly and Company, United States
  • Michael  Richardson, MD, FFPM
    Michael Richardson, MD, FFPM International GPV&E and EU QPPV
    Bristol-Myers Squibb, United Kingdom
  • Tracy M Salaam, PharmD
    Tracy M Salaam, PharmD Safety Evaluator Team Leader, CDER
    FDA, United States
  • E. Stewart  Geary, MD
    E. Stewart Geary, MD Senior VP, Chief Medical Officer, Director, Corporate Medical Affairs HQ
    Eisai Co., Ltd., Japan
Load More

Digital Learning Catalog

eLearning Catalog Cover
Read More